Does RELUGOLIX Cause Metastases to bone? 62 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 62 reports of Metastases to bone have been filed in association with RELUGOLIX (Orgovyx). This represents 0.3% of all adverse event reports for RELUGOLIX.
62
Reports of Metastases to bone with RELUGOLIX
0.3%
of all RELUGOLIX reports
7
Deaths
14
Hospitalizations
How Dangerous Is Metastases to bone From RELUGOLIX?
Of the 62 reports, 7 (11.3%) resulted in death, 14 (22.6%) required hospitalization.
Is Metastases to bone Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RELUGOLIX. However, 62 reports have been filed with the FAERS database.
What Other Side Effects Does RELUGOLIX Cause?
Hot flush (6,845)
Fatigue (5,203)
Therapy interrupted (3,251)
Incorrect dose administered (1,917)
Asthenia (1,718)
Arthralgia (1,385)
Diarrhoea (1,383)
Product dose omission issue (1,189)
Dizziness (1,146)
Constipation (902)
What Other Drugs Cause Metastases to bone?
LETROZOLE (1,735)
RIBOCICLIB (1,538)
FULVESTRANT (1,525)
ZOLEDRONIC ACID (1,087)
DENOSUMAB (1,053)
TAMOXIFEN (894)
LEUPROLIDE (848)
EVEROLIMUS (845)
PACLITAXEL (820)
PALBOCICLIB (793)
Which RELUGOLIX Alternatives Have Lower Metastases to bone Risk?
RELUGOLIX vs REMDESIVIR
RELUGOLIX vs REMERON
RELUGOLIX vs REMICADE
RELUGOLIX vs REMIFENTANIL
RELUGOLIX vs REMIMAZOLAM